FTC Issues Policy Statement on Patent Listing
By EsqSocial Corporation 19/09/23
The FTC is focusing its attention on the listing of pharmaceutical patents in the FDA’s Orange Book. Patent listing may be the subject of FTC inquiry even absent infringement litigation enforcing the relevant patents....
By: Dechert LLP